Skip to main content
logo
Acro Biomedical Co., Ltd. (ACBM)
OTCMKTS · Delayed Price · Currency is USD
0.0260
0.00 (0.00%)
At close: Jun 16, 2026

Acro Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2106270279
Market Cap Growth
3614.32%3071.46%-99.33%-97.67%-3.23%101.58%
Enterprise Value
2206270279
Last Close Price
0.030.020.000.104.504.65

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----410.31233.15
PB Ratio
-3.51-3.44-0.14-24.53555.52433.73
P/TBV Ratio
----555.52433.73
P/OCF Ratio
-----932.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----410.45233.04

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.87-0.84-0.52-0.550.220.11
Net Debt / Equity Ratio
-0.86-0.83-0.51-0.550.20-0.04
Asset Turnover
----0.911.36
Inventory Turnover
----43.171.95
Quick Ratio
0.010.010.000.003.207.56
Current Ratio
0.010.040.020.013.277.71
Return on Equity (ROE)
----7680.26%-2808.92%-1157.94%
Return on Assets (ROA)
-459.61%-417.89%-52.47%-1473.36%-1369.44%-546.69%
Return on Invested Capital (ROIC)
----4954.19%-2634.65%-989.64%
Return on Capital Employed (ROCE)
47.10%39.80%12.90%3820.80%-3262.90%-1149.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.99%-7.59%-100.64%-139.70%-5.87%-2.76%
Buyback Yield / Dilution
-----11.52%-12.73%